Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Pharmaceutical Drugs Global Market Report 2024
... Respiratory Disease Drugs; Vaccine And Therapeutic Nutrients; Minerals 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores 3) By Drug Classification: Branded Drugs; Generic Drugs 4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs; Prescription-Based ... Read More
-
Generic Pharmaceuticals Global Market Report 2024
... Channel: Hospital Pharmacies; Retail Pharmacies; And Online Pharmacies Covering: Teva Pharmaceutical Industries Ltd.; Novartis AG; Sun Pharmaceutical Industries Ltd.; Fresenius Kabi; Aurobindo Pharma Limited Generic Pharmaceuticals Global Market Report 2024 from The Business Research Company ... Read More
-
Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented by Molecule Type (Small Molecule, Large Molecule), By Synthesis (Biotech, Synthetic), By Drug Type (Innovative, Generics), By Workflow (Clinical, Commercial), By Application (Cardiology, Oncology, Ophthalmology, Neurology, Orthopedic, Other), By Region, By Competition
... Commercial), By Application (Cardiology, Oncology, Ophthalmology, Neurology, Orthopedic, Other), By Region, By Competition Global Active Pharmaceutical Ingredients CDMO Market was valued at USD 91.98 billion in 2023 and is anticipated to project robust growth in ... Read More
-
Generic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029). COVID-19 severely impacted the generic drugs market during the early pandemic due to lockdown restrictions and supply chain disruption. Later, there ... Read More
-
Global Branded Generics Market Growth 2024-2030
... Branded Generics is forecast to a readjusted size of US$ 540.5 million by 2030 with a CAGR of 8.5% during review period. The research report highlights the growth potential of the global Branded Generics market. ... Read More
-
Biologics Market Assessment, By Product [Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, Gene-Based Biologics, Therapeutic Enzymes, Others] By Application [Infectious Diseases, Cancer, Autoimmune Diseases, Cardiovascular, Hematological Disorders, Others] By Drug Classification [Branded Drugs, Generic Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F
... Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F Global biologics market size was valued at USD 401.34 billion in ... Read More
-
Inhalation And Nasal Spray Generic Drugs Global Market Report 2024
... Patient; Adult Patient; Pediatric Patient4) By End-User: Hospitals; HomecareCovering: Teva Pharmaceuticals Inc.; Sandoz International GmbH; Akorn Operating Company LLC; Cipla Inc.; Apotex Inc. Inhalation And Nasal Spray Generic Drugs Global Market Report 2024 from The ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032
... global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032. The ... Read More
-
Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
... generics market size reached US$ 19.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2024-2032, exhibiting a growth rate (CAGR) of 7.7% during 2032. The increasing prevalence ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2024-2032
... 38.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market ... Read More
-
Pharmaceutical Logistics Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Globalization and Focus on Cost-efficiency and Sustainability Driving Industry ... Read More
-
Generic Injectables Global Market Report 2024
... Pharmacy; Retail Pharmacy; Drug Stores; Online Prescription Stores5) By Application: Oncology; Diabetes; Infectious Diseases; Blood Disorders; Musculoskeletal Disorders; Hormonal Disorders; Pain Management; CNS Diseases; Cardiovascular DiseasesCovering: Baxter International Inc.; Sanofi SA; AstraZeneca plc.; Fresenius Medical ... Read More
-
Saudi Arabia Pharmaceutical Market - 2023-2030
... period 2023-2030. Pharmaceuticals range from developing, manufacturing, and marketing drugs. They range from large multinational corporations to small, specialized biotech startups. Pharmaceuticals are often referred to as various substances that are used in the diagnosis, ... Read More
-
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030. Global Pharmaceutical Marketing Market The pharmaceutical market, comprising the discovery, development, production, ... Read More
-
Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Global Forecast 2024-2030
... to reach USD 93.56 billion in 2024, at a CAGR 10.73% to reach USD 173.25 billion by 2030. Global Specialty Generics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Specialty ... Read More
-
Gastroesophageal Reflux Disease Therapeutics Market by Type (Branded, Generics), Drug Class (Aminosalicylates, Anti-Diarrheal, Anti-Emetics), Application - Global Forecast 2024-2030
... expected to reach USD 6.14 billion in 2024, at a CAGR 5.01% to reach USD 8.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gastroesophageal Reflux Disease Therapeutics ... Read More
-
Antiviral Drugs Market by Drug Type (Branded Drugs, Generic Drugs), Therapeutics (Acquired Immunodeficiency Syndrome Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics), End Use - Global Forecast 2024-2030
... at USD 56.22 billion in 2023 and expected to reach USD 59.84 billion in 2024, at a CAGR 6.54% to reach USD 87.61 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2024-2030
... and expected to reach USD 1.08 billion in 2024, at a CAGR 6.49% to reach USD 1.58 billion by 2030. Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method ... Read More
-
Fondaparinux Market by Product (Branded, Generics), Application (Ambulatory Surgical Centres, Clinics, Diagnostic centers) - Global Forecast 2024-2030
... million in 2024, at a CAGR 6.57% to reach USD 637.49 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Fondaparinux Market. It offers a comprehensive assessment of vendors, ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 33.12 billion in 2024, at a CAGR 10.57% to reach USD 60.66 billion by 2030. Global Generic Injectables MarketGeneric injectables are non-branded pharmaceuticals that are administered by injection and ... Read More
-
High Potency API Contract Manufacturing Market by Product Type (Generics, Innovative), Synthesis (Biotech, Synthetic), Dosage Form, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 12.95 billion in 2024, at a CAGR 10.24% to reach USD 23.36 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the High ... Read More
-
Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2024-2030
... expected to reach USD 19.03 billion in 2024, at a CAGR 8.78% to reach USD 31.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anxiety Drugs Market. It ... Read More
-
Global Markets for Generic Drugs
... report covers small molecule drugs and biosimilars. It includes market drivers and challenges in the generic drug industry. The competitive landscape includes generic drug sales of key competitors and their ranking in the market. It ... Read More
-
Active Pharmaceutical Ingredients CDMO Market (API-CDMO) by Drug (Generics, Innovative), Product (Antibody Drug Conjugate, Highly Potent Active Pharmaceutical Ingredient, Traditional Active Pharmaceutical Ingredient), Synthesis, Workflow, Application - Gl
... Market size was estimated at USD 114.85 billion in 2023 and expected to reach USD 126.42 billion in 2024, at a CAGR 10.38% to reach USD 229.39 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
Research Assistance
